Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)

SHA:688506 Revenue

Sichuan Biokin Pharmaceutical had revenue of 103.76M CNY in the quarter ending June 30, 2025, with 14.52% growth. This brings the company's revenue in the last twelve months to 441.19M, down -92.40% year-over-year. In the year 2024, Sichuan Biokin Pharmaceutical had annual revenue of 5.82B with 936.31% growth.

• Revenue (ttm): 441.19M
• Revenue Growth: -92.40%
• P/S Ratio: 328.66
• Revenue / Employee: 156.23K
• Employees: 2,521
• Market Cap: 145.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.82B	5.26B	936.31%
Dec 31, 2023	561.87M	-141.41M	-20.11%
Dec 31, 2022	703.28M	-93.45M	-11.73%
Dec 31, 2021	796.73M	-215.98M	-21.33%
Dec 31, 2020	1.01B	-193.91M	-16.07%